About Albert Holman
Albert Holman is a director at Ratio Therapeutics.
Albert Holman first appears on SEC filings in 2023.
Experience
This experience comes from Albert Holman's profile and from SEC filings. For roles taken from filings, the years are when the filings name Albert Holman in the role, so the role may have started earlier or lasted longer.
SC
Somerset Club Current
Treasurer
2026 – Present
Ratio Therapeutics, Inc. Current
Director
2021 – Present · Boston, MA
Develops targeted radioactive medicines for people with cancer.
BO
Boston Symphony Orchestra Current
Board Trustee or Committee Member
2015 – Present
MB
Mass General Brigham Current
Board Trustee or Committee Member
2008 – Present
CI
Chestnut Partners, Inc. Current
Founder and Co-Managing Partner
1995 – Present
HI
Helix Acquisition Corp. II
Board Member
2025
BH
Brigham and Women's Hospital
Secretary, Member of the Board of Trustees
1996 – 2024
ME
Medicalis
Member of the Board of Directors
2003 – 2017
KI
Kidder Peabody & Co. Incorporated
Managing Director, Investment Banking Department
1980 – 1994
Key Colleagues at Startups
The people Albert Holman works with at each company, as listed on that company's latest Form D.
Ratio Therapeutics, Inc. · Form D, Jul 31, 2026
SM
Scott MacDonald
Executive officer
MB
Marc Becker
Chief Financial Officer and Chief Operating Officer
BI
Brandon Ingersoll
Director
AG
Allan Green
Director
WC
William Cowan
Director
JH
John Hoppin
Chief Executive Officer and director
JB
John Babich
Chief Scientific Officer and director
SW
Susan Whoriskey
Director